Show simple item record

dc.creatorOkie, Susanen
dc.date.accessioned2011-07-12T18:36:45Zen
dc.date.available2011-07-12T18:36:45Zen
dc.date.created1999-06-22en
dc.date.issued1999-06-22en
dc.identifierhttp://www.washingtonpost.comen
dc.identifier.bibliographicCitationWashington Post Health 1999 June 22; 15(25): 7en
dc.identifier.urihttp://hdl.handle.net/10822/535688en
dc.formatNews Articleen
dc.languageengen
dc.source204674en
dc.subjectBlooden
dc.subjectGene Therapyen
dc.subjectGenesen
dc.subjectHemophiliaen
dc.subjectPatientsen
dc.subject.classificationGene Therapy / Gene Transferen
dc.subject.classificationResearch on Special Populationsen
dc.titleGene Therapy Aims to Cure Hemophilia: Patients in Trial Receive Replacement Genes to Correct Blood Clotting Disorderen
dc.provenanceDigital citation created by the Bioethics Research Library, Georgetown University, for the National Information Resource on Ethics and Human Genetics, a project funded by the United States National Human Genome Research Instituteen
dc.provenanceDigital citation migrated from OpenText Livelink Discovery Server database named GenETHX to DSpace collection GenETHX hosted by Georgetown Universityen


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2019 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885